Refreshed content for Tesamorelinai_activityai-researcherApr 17, 2026
Pulled 3 linked studies for context.
No external link
Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Research footprint
Last analyzed Apr 17, 20265
Studies indexed
0
Human
0
Animal
2
AI analyzed
Evidence mix0% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2026
Librarian pulse — latest actionsFull changelog ↓
- Apr 17, 12:04 PMRefreshedRefreshed content for Tesamorelin
- Apr 16, 5:14 PMRefreshedRefreshed content for Tesamorelin
- Apr 16, 5:14 PMRefreshedRefreshed content for Tesamorelin
Research & intelligence feed
Studies, clinical trials, community discussions, and news.
Refreshed content for Tesamorelinai_activityai-researcherApr 16, 2026
Pulled 3 linked studies for context. - **content** added: Body content generated (1307 chars).
No external link
Refreshed content for Tesamorelinai_activityai-researcherApr 16, 2026
Pulled 3 linked studies for context. - **content** added: Body content generated (1201 chars).
No external link
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Tesamorelin (GHRH Analog) for Reducing Hepatic Steatosis in Adults With Metabolic Associated Steatotic Liver Disease (MASLD)Clinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the effects of Tesamorelin, a GHRH analog, on hepatic steatosis in adults diagnosed with Metabolic Associated Steatotic Liver Disease (MASLD). The study was randomized, double-blind, and placebo-controlled. Not reported in abstract.
Phase: PHASE2Status: RECRUITING
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®Clinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the safety of Tesamorelin in subjects with HIV-associated abdominal lipohypertrophy over a 10-year period. It compared outcomes between those exposed to Tesamorelin and a similar group not exposed. No therapeutic claims are made regarding the efficacy of the treatment.
Status: TERMINATED
Semantic Scholar search for TesamorelinStudySemanticScholarDec 12, 2025
Metabolic dysfunction-associated steatotic liver disease in people with HIV.StudyPubMedDec 12, 2025
Current opinion in HIV and AIDS · 2025
Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study.StudyPubMedDec 12, 2025
Cureus · 2025
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Community notes
No comments yet. Share research notes, citations, or observations below.
Community research logs (detail)
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Librarian Changelog
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
22h agoRefreshai-researcher85%
Refreshed content for Tesamorelin
1d agoRefreshai-researcher85%
Refreshed content for Tesamorelin
1d agoRefreshai-researcher85%
Refreshed content for Tesamorelin